2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
| 热门AI工具: |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | DRUG DEVELOPMENT RESEARCH DRUG DEVELOP RES (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.1
53人评分
我要评分
声誉 6.3 影响力 3.8 速度 6.9 | |||||||||||||||||
| 期刊ISSN | 0272-4391 | 安装APP,查看期刊最新消息
| ||||||||||||||||
| E-ISSN | 1098-2299 | |||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:4.16 | |||||||||||||||||
| 2025-2026自引率 | 2.4%点击查看自引率趋势图 | |||||||||||||||||
| 五年IF (数据来源于网友提供) | 4.197数据由网友[lunarmatcha421]收集提供 | |||||||||||||||||
| h-index | 54 | |||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||
| 期刊简介 |
| |||||||||||||||||
| 期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2299 | |||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||
| 期刊投稿网址 | https://mc.manuscriptcentral.com/ddr | |||||||||||||||||
| 该期刊中国学者近期发文 - New | Tricin Inhibits Human Osteosarcoma Cell Metastasis via Suppression of ZNF503 and the PI3K-PIP3-Akt Pathway Author: Chou, Chia-Hsuan; Yang, Jia-Sin; Chen, Pei-Ni; Hsieh, Yi-Hsien; Tang, Chih-Hsin; Lin, Ya-Chiu; Yang, Shun-Fa; Lu, Ko-Hsiu Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70374 TEAD1 Knockdown Ameliorates Diabetic Erectile Dysfunction in Rats and Is Associated With Modulation of Calcium Signaling-Mediated Contractile Machinery Author: Zhang, Tao; Wu, Chenxiao; Lu, Youlong; Li, Weili; Zhang, Huaru; Li, Cheng Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70365 DSCAM-AS1 Facilitates Osteosarcoma Progression via Regulating miR-211-5p/PDCD6 Axis Author: Wang, Qi; Zhao, Yunzheng; Shi, Longyan; Liu, Hongjian; Liu, Qiuliang Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70360 Dioscin Reverses Drug Resistance via AKT/GSK3β-mediated P-gp Degradation and EMT Inhibition Author: Zhang, Keqi; Zhao, Jinzhu; Li, Linlin; Wang, Zixin; Mao, Xinyi; Yan, Jie; Han, Shuhua; He, Mingjing; Bi, Bingjie; Xu, Qiang; Wang, Cong Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70366 | |||||||||||||||||
| 期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足DRUG DEVELOPMENT RESEARCH的语言要求,还能让DRUG DEVELOPMENT RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被DRUG DEVELOPMENT RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(2篇) 。 提交文稿 | |||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||
| 通讯方式 | WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030 | |||||||||||||||||
| 出版商 | John Wiley and Sons Inc. | |||||||||||||||||
| 涉及的研究方向 | 医学-药学 | |||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||
| 出版语言 | English | |||||||||||||||||
| 出版周期 | Bimonthly | |||||||||||||||||
| 出版年份 | 1981 | |||||||||||||||||
| 年文章数 | 169点击查看年文章数趋势图 | |||||||||||||||||
| Gold OA文章占比 | 13.18% | |||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 75.74% | |||||||||||||||||
| WOS期刊JCR分区 ( 2025-2026年最新版) | 注册或登录后,查看WOS分区等级 | |||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0272-4391%5BISSN%5D | |||||||||||||||||
| 平均审稿速度 | 网友分享经验: 较慢,6-12周 | |||||||||||||||||
| 平均录用比例 | 网友分享经验: 容易 | |||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在DRUG DEVELOPMENT RESEARCH顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(2篇) 。 提交文稿 | |||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Tricin Inhibits Human Osteosarcoma Cell Metastasis via Suppression of ZNF503 and the PI3K-PIP3-Akt Pathway Author: Chou, Chia-Hsuan; Yang, Jia-Sin; Chen, Pei-Ni; Hsieh, Yi-Hsien; Tang, Chih-Hsin; Lin, Ya-Chiu; Yang, Shun-Fa; Lu, Ko-Hsiu Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70374 PubMed DOI |
| 2. | TEAD1 Knockdown Ameliorates Diabetic Erectile Dysfunction in Rats and Is Associated With Modulation of Calcium Signaling-Mediated Contractile Machinery Author: Zhang, Tao; Wu, Chenxiao; Lu, Youlong; Li, Weili; Zhang, Huaru; Li, Cheng Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70365 PubMed DOI |
| 3. | DSCAM-AS1 Facilitates Osteosarcoma Progression via Regulating miR-211-5p/PDCD6 Axis Author: Wang, Qi; Zhao, Yunzheng; Shi, Longyan; Liu, Hongjian; Liu, Qiuliang Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70360 PubMed DOI |
| 4. | Dioscin Reverses Drug Resistance via AKT/GSK3β-mediated P-gp Degradation and EMT Inhibition Author: Zhang, Keqi; Zhao, Jinzhu; Li, Linlin; Wang, Zixin; Mao, Xinyi; Yan, Jie; Han, Shuhua; He, Mingjing; Bi, Bingjie; Xu, Qiang; Wang, Cong Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 6, pp. -. DOI: 10.1002/ddr.70366 PubMed DOI |
| 5. | Alternative Splicing in Cyclin-Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer Author: Cui, Yuqiu; Xie, Jia; Cai, Jiale; Si, Yue; Huang, Hairong; Yu, Shiyi; Sun, Haibo Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 5, pp. -. DOI: 10.1002/ddr.70354 PubMed DOI |
| 6. | GRP78 Drives NSCLC Stemness and EMT via a SIX1/β-Catenin Signaling Axis Author: Tong, Guoping; Qi, Huanyu Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 5, pp. -. DOI: 10.1002/ddr.70359 PubMed DOI |
| 7. | Discovery of Novel PCSK9-LDLR PPI Inhibitors by a Structural Modification Approach Author: Zhu, Huan; Zhang, Zhiqin; Zhang, Lihui; Cao, Jiangying; Zhang, Lei Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 5, pp. -. DOI: 10.1002/ddr.70352 PubMed DOI |
| 8. | Design, Synthesis, and Evaluation of the Novel Benzimidazole Derivatives Inspired YC-1 as HIF-1α Inhibitor That Possess Anti-Colon Cancer Potential Author: Yang, Qixian; Zhang, Jing; Liu, Meijing; Deng, Xiangping; Xie, Zhizhong; Lei, Xiaoyong; Yang, Xiaoyan; Tang, Guotao; Wang, Zhe Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 5, pp. -. DOI: 10.1002/ddr.70347 PubMed DOI |
| 9. | TRIM38 Alleviates Ferroptosis in Heart Failure by Inactivating the TRAF6-p38 MAPK Pathway via Ubiquitinating Degradation of IRAK1 Author: Liu, Yun; Jia, Haiyu; Zhang, Yong; Bao, Qiuhong Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 5, pp. -. DOI: 10.1002/ddr.70340 PubMed DOI |
| 10. | Contrastive Learning-Powered Ultrafast Genome-Wide Virtual Screening: The Rise of DrugCLIP Author: Zhang, Jinwei Journal: DRUG DEVELOPMENT RESEARCH. 2026; Vol. 87, Issue 5, pp. -. DOI: 10.1002/ddr.70351 PubMed DOI |
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共22条 |
||||||||||||||||
|
|

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室